Condition Lookup
Category:
CNS Infections
Number of Conditions: 36
Meningitis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
severe headache; stiff neck; fever; nausea and vomiting; sensitivity to light (photophobia); altered mental status; seizures
Root Cause:
Inflammation of the meninges caused by bacterial, viral, fungal, or parasitic infections.
How it's Diagnosed: videos
Diagnosed through lumbar puncture to analyze CSF, along with blood cultures, and imaging (CT or MRI).
Treatment:
Depends on the cause; bacterial meningitis requires immediate intravenous antibiotics and corticosteroids. Viral meningitis is usually self-limiting and treated supportively.
Medications:
For bacterial meningitis - Third-generation cephalosporins (e.g., ceftriaxone ) and vancomycin ; adjunctive corticosteroids like dexamethasone reduce inflammation. For viral meningitis - Antiviral drugs like acyclovir (for herpes simplex virus) and symptomatic medications.
Prevalence:
How common the health condition is within a specific population.
Annual global incidence varies; bacterial meningitis affects approximately 2.8 per 100,000 annually.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Crowded living conditions, immunosuppression, age extremes (infants and elderly), head trauma, and lack of vaccination.
Prognosis:
The expected outcome or course of the condition over time.
Bacterial meningitis has a high mortality if untreated, but early treatment improves outcomes. Viral meningitis typically has a better prognosis.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Hearing loss, cognitive impairment, seizures, and hydrocephalus.
Ventilator-Associated Pneumonia (VAP)
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; increased respiratory secretions; difficulty breathing; low oxygen saturation; altered mental status
Root Cause:
Pneumonia caused by bacterial colonization of the airway in mechanically ventilated patients, often involving multidrug-resistant organisms.
How it's Diagnosed: videos
Clinical signs, chest imaging (e.g., infiltrates on chest X-ray), and microbiological analysis of respiratory secretions.
Treatment:
Broad-spectrum antibiotics tailored to identified pathogens, optimization of ventilator settings, and infection control measures.
Medications:
Empiric antibiotics (e.g., piperacillin-tazobactam, vancomycin ); specific antibiotics based on culture results (e.g., meropenem for resistant Gram-negative organisms).
Prevalence:
How common the health condition is within a specific population.
Common in ICUs, affecting 10–20% of mechanically ventilated patients.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Prolonged mechanical ventilation, immunosuppression, prior antibiotic use, and poor oral hygiene.
Prognosis:
The expected outcome or course of the condition over time.
Variable; early treatment improves outcomes, but VAP can lead to prolonged hospitalization or death in severe cases.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Sepsis, acute respiratory distress syndrome (ARDS), multi-organ failure, and prolonged hospital stay.
Acute Disseminated Encephalomyelitis (ADEM)
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; headache; nausea; vomiting; confusion; seizures; motor weakness; vision problems; lethargy
Root Cause:
An autoimmune response often triggered by an infection or, less commonly, vaccination, causing inflammation and demyelination in the brain and spinal cord.
How it's Diagnosed: videos
Clinical evaluation, MRI of the brain (showing diffuse demyelination), lumbar puncture (to analyze cerebrospinal fluid), and exclusion of other conditions like multiple sclerosis.
Treatment:
High-dose corticosteroids (e.g., methylprednisolone), plasma exchange (plasmapheresis), intravenous immunoglobulin (IVIG), and supportive care.
Medications:
Corticosteroids (e.g., methylprednisolone for reducing inflammation), IVIG (immunomodulatory therapy), or plasmapheresis (used when steroids are insufficient). Corticosteroids are classified as anti-inflammatory agents.
Prevalence:
How common the health condition is within a specific population.
Rare; estimated annual incidence is 0.4-0.8 per 100,000 people, more common in children than adults.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Recent viral or bacterial infections, recent vaccination, genetic predisposition, or underlying autoimmune disorders.
Prognosis:
The expected outcome or course of the condition over time.
Good in most cases; symptoms often resolve with treatment, although some individuals may experience residual neurological deficits.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Long-term neurological impairment, recurrence (though rare), or progression to conditions like multiple sclerosis in some cases.
Brain Abscess
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
headache; fever; nausea; vomiting; neurological deficits; seizures; altered mental status
Root Cause:
Focal collection of pus in the brain tissue, often caused by bacterial or fungal infections entering through the bloodstream, contiguous spread, or trauma.
How it's Diagnosed: videos
MRI or CT scan with contrast, blood cultures, and biopsy of the abscess for microbiological testing.
Treatment:
Surgical drainage or aspiration, combined with broad-spectrum antibiotics tailored based on culture results.
Medications:
Antibiotics such as ceftriaxone (a cephalosporin) or metronidazole (an anti-anaerobic agent). For fungal infections, amphotericin B or fluconazole may be used.
Prevalence:
How common the health condition is within a specific population.
Rare, with an estimated incidence of 0.3 to 1.3 cases per 100,000 people annually.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Immunocompromised status (HIV, organ transplantation), chronic sinusitis, otitis media, congenital heart defects, head trauma.
Prognosis:
The expected outcome or course of the condition over time.
With prompt treatment, mortality rates are around 10–20%, but neurological deficits may persist.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Increased intracranial pressure, brain herniation, seizures, recurrence of infection, or neurological impairments.
Neurocysticercosis
Specialty: Infectious Diseases
Category: CNS Infections
Sub-category: Parasitic Infections
Symptoms:
seizures; headache; nausea; vomiting; vision problems; hydrocephalus; altered mental status
Root Cause:
Infection of the central nervous system by Taenia solium larvae (pork tapeworm), leading to cyst formation in the brain.
How it's Diagnosed: videos
Neuroimaging (MRI or CT) revealing cysts or calcifications, serologic tests for T. solium antibodies, and CSF analysis.
Treatment:
Antiparasitic therapy with albendazole or praziquantel, corticosteroids to reduce inflammation, anticonvulsants for seizure management, and surgical intervention in severe cases.
Medications:
Albendazole (antiparasitic), praziquantel (antiparasitic), dexamethasone (corticosteroid), and levetiracetam or phenytoin (anticonvulsants).
Prevalence:
How common the health condition is within a specific population.
Leading cause of acquired epilepsy in developing countries; affects millions globally, particularly in regions with poor sanitation.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Consumption of undercooked pork, poor sanitation, close contact with infected individuals, and living in endemic areas.
Prognosis:
The expected outcome or course of the condition over time.
Favorable with treatment in uncomplicated cases; long-term anticonvulsant therapy may be required for seizure control.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Chronic epilepsy, hydrocephalus, intracranial hypertension, and neurological deficits.
Bacterial Meningitis (Empiric Therapy)
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; neck stiffness; severe headache; nausea; vomiting; photophobia; altered mental status; seizures
Root Cause:
Acute inflammation of the meninges caused by bacterial infection.
How it's Diagnosed: videos
Clinical examination, lumbar puncture with cerebrospinal fluid (CSF) analysis (showing elevated white cell count, low glucose, and high protein), blood cultures, and imaging (CT or MRI if indicated).
Treatment:
Empiric antibiotic therapy (before the causative organism is identified), adjunctive corticosteroids, and supportive care.
Medications:
Empiric therapy often includes ceftriaxone or cefotaxime (3rd generation cephalosporins, broad-spectrum antibiotics), vancomycin (to cover resistant strains), and ampicillin (to cover Listeria monocytogenes in specific populations). Corticosteroids like dexamethasone are used to reduce inflammation.
Prevalence:
How common the health condition is within a specific population.
Incidence varies by region and age group; approximately 2-5 cases per 100,000 people annually in developed countries.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Immunosuppression, head trauma, invasive procedures, close contact with infected individuals, crowded living conditions, and extremes of age (infants and elderly).
Prognosis:
The expected outcome or course of the condition over time.
With prompt treatment, mortality is 5-30%, but delays in therapy significantly worsen outcomes. Neurological sequelae like hearing loss can occur.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Sepsis, increased intracranial pressure, stroke, seizures, and long-term neurological damage.
Bacterial Meningitis (Organism-Specific Therapy)
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; neck stiffness; severe headache; nausea; vomiting; photophobia; altered mental status; seizures
Root Cause:
Inflammation of the meninges caused by specific bacterial pathogens like Neisseria meningitidis, Streptococcus pneumoniae, or Listeria monocytogenes.
How it's Diagnosed: videos
Identification of causative organism through cerebrospinal fluid (CSF) culture or polymerase chain reaction (PCR), blood cultures, and gram staining.
Treatment:
Targeted antibiotic therapy based on organism and susceptibility, adjunctive corticosteroids in certain cases, and supportive measures.
Medications:
For Neisseria meningitidis - Ceftriaxone or cefotaxime (3rd generation cephalosporins). For Streptococcus pneumoniae - Vancomycin plus ceftriaxone or cefotaxime . For Listeria monocytogenes - Ampicillin or penicillin G, often combined with gentamicin . Corticosteroids (e.g., dexamethasone ) to reduce inflammatory response in specific cases.
Prevalence:
How common the health condition is within a specific population.
Variable depending on region and vaccination coverage; more common in low-resource settings.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Age, immunodeficiency, lack of vaccination, recent head trauma or surgery, and close contact with infected individuals.
Prognosis:
The expected outcome or course of the condition over time.
Depends on early identification and treatment; targeted therapy improves outcomes, but significant mortality and morbidity can occur in severe cases.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Neurological deficits, hearing loss, hydrocephalus, brain abscess, or death.
California Encephalitis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; headache; nausea; vomiting; seizures; lethargy; meningeal irritation; neurological impairments in severe cases
Root Cause:
Viral infection caused by California serogroup viruses (e.g., La Crosse virus), primarily transmitted through mosquito bites.
How it's Diagnosed: videos
Clinical evaluation, lumbar puncture with cerebrospinal fluid (CSF) analysis, serologic or PCR testing for viral RNA.
Treatment:
Supportive care including antipyretics, anticonvulsants, and management of intracranial pressure.
Medications:
No specific antiviral therapy; symptomatic treatment includes antipyretics like acetaminophen and anticonvulsants like levetiracetam .
Prevalence:
How common the health condition is within a specific population.
Rare; typically affects children and adolescents in endemic regions of the United States.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Exposure to mosquito bites, residence in or travel to endemic areas, outdoor activities during peak mosquito seasons.
Prognosis:
The expected outcome or course of the condition over time.
Most cases resolve with supportive care, but severe cases may lead to neurological sequelae or death.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Seizures, cognitive impairment, behavioral changes, or chronic neurological deficits in severe cases.
CNS Whipple Disease
Specialty: Infectious Diseases
Category: CNS Infections
Sub-category: Rare Bacterial Infections
Symptoms:
cognitive dysfunction; ophthalmoplegia; seizures; ataxia; headache; weight loss; joint pain
Root Cause:
Caused by Tropheryma whipplei, a rare bacterial infection leading to systemic and neurological symptoms.
How it's Diagnosed: videos
PCR testing for Tropheryma whipplei in CSF or tissue biopsy, histopathology with PAS-positive macrophages, and endoscopic biopsy of the duodenum.
Treatment:
Long-term antibiotic therapy, typically starting with intravenous ceftriaxone followed by oral trimethoprim-sulfamethoxazole for one year.
Medications:
Ceftriaxone (IV beta-lactam antibiotic) followed by oral trimethoprim-sulfamethoxazole (a sulfonamide antimicrobial combination).
Prevalence:
How common the health condition is within a specific population.
Extremely rare; precise prevalence is unknown but estimated at less than 1 per 1,000,000 people annually.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Middle-aged males, HLA-B27 positivity, and immunosuppression.
Prognosis:
The expected outcome or course of the condition over time.
Early treatment can lead to full recovery, but delayed diagnosis increases the risk of irreversible neurological damage.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Cognitive impairment, seizures, motor dysfunction, and death if untreated.
Cysticercosis (Pork Tapeworm Infection)
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
seizures; headaches; confusion; intracranial hypertension; vision changes; nausea; vomiting
Root Cause:
Infection with Taenia solium larvae, often acquired through ingestion of food or water contaminated with eggs of the pork tapeworm.
How it's Diagnosed: videos
MRI or CT scans to detect cysts in the brain, serologic tests (enzyme-linked immunoelectrotransfer blot), and patient history of exposure.
Treatment:
Combination of antiparasitic therapy, corticosteroids, and symptomatic treatment. Surgery may be required in some cases to remove cysts or relieve pressure.
Medications:
Antiparasitic medications include albendazole or praziquantel (antihelminthic drugs). Corticosteroids such as dexamethasone or prednisone are used to control inflammation. Antiepileptic drugs (e.g., phenytoin , carbamazepine ) are prescribed to manage seizures.
Prevalence:
How common the health condition is within a specific population.
Endemic in developing countries, particularly in areas with poor sanitation and where pigs are raised. Prevalence varies widely but is common in parts of Latin America, Africa, and Asia.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Consumption of undercooked pork, poor sanitation, exposure to feces contaminated with Taenia solium eggs.
Prognosis:
The expected outcome or course of the condition over time.
With prompt diagnosis and treatment, prognosis is generally good, although chronic neurological effects may persist in severe cases.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Hydrocephalus, chronic seizures, encephalitis, and death in severe untreated cases.
Eastern Equine Encephalitis (EEE)
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
high fever; stiff neck; severe headache; vomiting; drowsiness; confusion; seizures; coma
Root Cause:
Infection caused by the Eastern Equine Encephalitis virus (EEEV), transmitted through the bite of an infected mosquito.
How it's Diagnosed: videos
Diagnosis is made through serologic tests (detection of IgM antibodies in cerebrospinal fluid or serum), PCR, or viral isolation from samples.
Treatment:
Supportive care, including respiratory support, anticonvulsants for seizures, and fluids for dehydration. No specific antiviral treatment is available.
Medications:
No direct antiviral medications; symptomatic treatments include anticonvulsants (e.g., levetiracetam or valproic acid) and medications to manage complications such as swelling in the brain (e.g., mannitol or corticosteroids).
Prevalence:
How common the health condition is within a specific population.
Rare but more common in the eastern United States, primarily in areas with wetland habitats. Annual cases are low, typically fewer than 10 per year in the U.S.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Living in or traveling to areas with high mosquito populations, outdoor exposure without protective measures.
Prognosis:
The expected outcome or course of the condition over time.
High mortality rate (approximately 30%); survivors often have long-term neurological sequelae.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Severe neurological damage, paralysis, intellectual disability, and death.
Haemophilus Meningitis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; stiff neck; headache; nausea; vomiting; sensitivity to light; altered mental status; seizures
Root Cause:
Bacterial infection caused by Haemophilus influenzae type b (Hib), leading to inflammation of the meninges.
How it's Diagnosed: videos
Lumbar puncture for cerebrospinal fluid analysis, Gram staining, and culture; PCR tests for Hib DNA.
Treatment:
Intravenous antibiotics and supportive care.
Medications:
Third-generation cephalosporins like ceftriaxone or cefotaxime are the antibiotics of choice. Adjunctive dexamethasone may be used to reduce inflammation.
Prevalence:
How common the health condition is within a specific population.
Rare in countries with widespread Hib vaccination; still occurs in unvaccinated populations or areas with low vaccine coverage.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Lack of vaccination, young age (children under 5), weakened immune system.
Prognosis:
The expected outcome or course of the condition over time.
With prompt antibiotic treatment, prognosis is good, although complications such as hearing loss may occur.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Hearing loss, intellectual disability, seizures, and death if untreated.
Herpes Simplex Encephalitis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; headache; altered mental status; seizures; personality changes; weakness; memory disturbances
Root Cause:
Viral infection caused by herpes simplex virus (HSV-1 or HSV-2), leading to inflammation and damage to brain tissue.
How it's Diagnosed: videos
MRI showing temporal lobe abnormalities, CSF analysis with PCR to detect HSV DNA, and EEG.
Treatment:
Antiviral therapy with supportive care.
Medications:
Acyclovir (antiviral medication) is the first-line treatment.
Prevalence:
How common the health condition is within a specific population.
Rare but serious, with an incidence of approximately 2–4 cases per million per year.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Prior HSV infections, immunosuppression, neonates (HSV-2), and older adults.
Prognosis:
The expected outcome or course of the condition over time.
Without treatment, mortality exceeds 70%; with prompt antiviral therapy, mortality is reduced to around 20%, though neurological sequelae are common.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Persistent neurological deficits, cognitive impairments, seizures, and death if untreated.
Infectious Myositis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
muscle pain; swelling; weakness; fever; redness or warmth over affected muscles
Root Cause:
Infection of skeletal muscle caused by bacteria (e.g., Staphylococcus aureus), viruses (e.g., influenza), parasites (e.g., Trichinella spiralis), or fungi.
How it's Diagnosed: videos
Blood tests (elevated creatine kinase), imaging (MRI, ultrasound), and muscle biopsy.
Treatment:
Antibiotics for bacterial infections, antivirals for viral causes, antiparasitic medications, or antifungal drugs, depending on the underlying organism.
Medications:
Antibiotics such as clindamycin or vancomycin for bacterial infections; antiparasitic drugs like albendazole for parasitic causes; antifungal agents like amphotericin B for fungal infections.
Prevalence:
How common the health condition is within a specific population.
Rare; varies depending on the causative organism and geographic region.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Recent infections, immunosuppression, trauma to muscle, travel to endemic areas (for parasitic causes).
Prognosis:
The expected outcome or course of the condition over time.
Generally good with appropriate treatment; untreated cases can lead to severe complications.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Abscess formation, sepsis, rhabdomyolysis, and systemic spread of infection.
Intracranial Epidural Abscess
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
severe headache; nausea and vomiting; fever; seizures; neurological deficits; confusion or altered mental status
Root Cause:
A collection of pus between the skull and the dura mater, often caused by bacterial infection from sinusitis, otitis media, or trauma.
How it's Diagnosed: videos
Diagnosed through imaging (MRI or CT scan) and laboratory studies, including blood cultures and cerebrospinal fluid (CSF) analysis (if necessary).
Treatment:
Surgical drainage of the abscess combined with targeted antibiotic therapy.
Medications:
Antibiotics such as vancomycin and ceftriaxone (broad-spectrum) or metronidazole (for anaerobic coverage). These are antimicrobial agents tailored to the suspected causative organisms.
Prevalence:
How common the health condition is within a specific population.
Rare, accounting for less than 1% of all intracranial infections.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Chronic sinusitis, otitis media, head trauma, neurosurgical procedures, and immunosuppression.
Prognosis:
The expected outcome or course of the condition over time.
Generally good with prompt surgical and medical treatment, but delayed intervention can lead to permanent neurological damage or death.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Meningitis, brain abscess, venous sinus thrombosis, or neurological deficits.
Japanese Encephalitis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; headache; nausea and vomiting; seizures; confusion; movement disorders; coma in severe cases
Root Cause:
Viral infection caused by the Japanese encephalitis virus (JEV), transmitted by Culex mosquitoes, leading to inflammation of the brain.
How it's Diagnosed: videos
Diagnosed through serological tests like IgM antibody capture ELISA (MAC-ELISA) in CSF or blood samples, and imaging (MRI).
Treatment:
Supportive care to manage symptoms, such as antipyretics for fever and anticonvulsants for seizures. No specific antiviral treatment.
Medications:
Supportive medications include anticonvulsants (e.g., phenytoin or levetiracetam ) and antipyretics (e.g., acetaminophen ). These are symptom-relieving drugs.
Prevalence:
How common the health condition is within a specific population.
Endemic in parts of Asia and the Western Pacific; affects approximately 50,000–100,000 people annually.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Living in or traveling to endemic areas, exposure to mosquito bites, and lack of vaccination.
Prognosis:
The expected outcome or course of the condition over time.
Mortality rate is 20–30%, and 30–50% of survivors have significant neurological or psychiatric sequelae.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Seizures, permanent neurological disabilities, movement disorders, and behavioral issues.
Meningococcal Meningitis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
sudden onset of fever; severe headache; stiff neck; nausea and vomiting; photophobia; altered mental status; petechial or purpuric rash
Root Cause:
Bacterial infection caused by Neisseria meningitidis, leading to inflammation of the meninges and potential systemic involvement.
How it's Diagnosed: videos
Confirmed through lumbar puncture (CSF analysis for Gram stain and culture) and blood cultures; PCR testing for rapid identification.
Treatment:
Empiric antibiotic therapy with third-generation cephalosporins (e.g., ceftriaxone) and close-contact prophylaxis with rifampin or ciprofloxacin.
Medications:
Antibiotics - Ceftriaxone or penicillin G (specific antimicrobial therapy). Corticosteroids - Dexamethasone (adjunct to reduce inflammation). Prophylactic - Rifampin , ciprofloxacin , or ceftriaxone for close contacts.
Prevalence:
How common the health condition is within a specific population.
Incidence varies globally; outbreaks are common in the African meningitis belt.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Crowded living conditions, close contact with an infected person, smoking, and complement deficiencies.
Prognosis:
The expected outcome or course of the condition over time.
Mortality rate is 10–15% even with treatment; survivors may have permanent disabilities.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Septicemia, limb gangrene, disseminated intravascular coagulation (DIC), hearing loss, and brain damage.
Naegleria Infection and Primary Amebic Meningoencephalitis (PAM)
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
severe headache; fever; nausea; vomiting; stiff neck; seizures; altered mental status; hallucinations; coma
Root Cause:
Infection caused by the amoeba Naegleria fowleri, which invades the brain through the nasal passages, often following freshwater exposure.
How it's Diagnosed: videos
Analysis of cerebrospinal fluid (CSF) through lumbar puncture, identification of Naegleria in CSF via microscopy, polymerase chain reaction (PCR), or antigen testing; brain imaging (MRI or CT) for inflammation.
Treatment:
Aggressive antimicrobial therapy including amphotericin B (intravenous and intrathecal), supportive care for cerebral edema, and experimental medications like miltefosine.
Medications:
Amphotericin B (antifungal), miltefosine (antiparasitic), rifampin (antibiotic), fluconazole (antifungal), and azithromycin (antibiotic). These medications aim to target the amoeba directly and reduce associated inflammation.
Prevalence:
How common the health condition is within a specific population.
Rare; fewer than 150 cases reported in the United States over several decades. Occurs more frequently in warm climates with freshwater exposure.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Freshwater swimming or diving, particularly in warm lakes or hot springs; use of untreated water for nasal irrigation.
Prognosis:
The expected outcome or course of the condition over time.
Poor, with a mortality rate exceeding 97%; early diagnosis and treatment are critical for the few known survivors.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Rapidly progressing brain inflammation, brain herniation, coma, and death.
Neonatal Meningitis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; lethargy; poor feeding; irritability; seizures; bulging fontanel; stiff neck; vomiting; difficulty breathing
Root Cause:
Bacterial or viral infection in the meninges of the brain and spinal cord, often caused by pathogens like Group B Streptococcus, E. coli, or Listeria monocytogenes.
How it's Diagnosed: videos
Lumbar puncture for CSF analysis (elevated white cells, protein, decreased glucose), blood cultures, neuroimaging (MRI or CT), and specific PCR tests for pathogens.
Treatment:
Intravenous broad-spectrum antibiotics (e.g., ampicillin and gentamicin) followed by pathogen-specific therapy; antiviral medications for viral causes; supportive care for seizures and hydration.
Medications:
Antibiotics such as ampicillin (penicillin class), gentamicin (aminoglycoside), cefotaxime (cephalosporin), and acyclovir (antiviral for suspected herpes infection).
Prevalence:
How common the health condition is within a specific population.
Occurs in 1-3 cases per 1,000 live births in developed countries, higher prevalence in low-resource settings.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Premature birth, maternal infection, prolonged labor, low birth weight, and exposure to group B strep during delivery.
Prognosis:
The expected outcome or course of the condition over time.
Variable; high risk of mortality (10-15%) and neurodevelopmental sequelae in survivors (e.g., hearing loss, cerebral palsy).
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Sepsis, brain abscesses, hydrocephalus, and developmental delays.
Neurological Sequelae of Infectious Endocarditis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
stroke-like symptoms; seizures; headache; altered mental status; focal neurological deficits; meningismus
Root Cause:
Embolic events or septic emboli originating from the infected cardiac valves can cause ischemic or hemorrhagic strokes, abscesses, and inflammation in the central nervous system (CNS).
How it's Diagnosed: videos
Clinical history, blood cultures to identify causative organism, imaging studies like MRI or CT to detect CNS involvement, echocardiography (transesophageal preferred) to assess for vegetations on heart valves.
Treatment:
Combination of prolonged intravenous antibiotics tailored to the causative organism, surgical intervention for infected valves if indicated, and supportive care for neurological complications.
Medications:
Antibiotics such as ceftriaxone , vancomycin , or gentamicin , depending on the identified pathogen (beta-lactams, glycopeptides, or aminoglycosides, respectively). Antiepileptics (e.g., levetiracetam ) if seizures occur.
Prevalence:
How common the health condition is within a specific population.
Rare but significant; approximately 20–40% of patients with infectious endocarditis develop neurological complications.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Intravenous drug use, pre-existing heart valve disease, prosthetic heart valves, immunosuppression, poor dental hygiene.
Prognosis:
The expected outcome or course of the condition over time.
Prognosis depends on promptness of treatment and severity of neurological complications; early intervention improves outcomes, but severe neurological deficits may persist.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Ischemic stroke, cerebral abscess, intracranial hemorrhage, meningitis, persistent neurological deficits, and risk of recurrent endocarditis.
Prion-Related Diseases
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
rapidly progressive dementia; ataxia; myoclonus; visual disturbances; behavioral changes; seizures in advanced cases
Root Cause:
Accumulation of abnormal prion proteins (PrP^Sc) in the brain leads to neurodegeneration, forming sponge-like brain tissue changes.
How it's Diagnosed: videos
Clinical history, EEG (showing periodic sharp wave complexes in some cases), MRI brain (characteristic signal changes in basal ganglia and cortex), CSF biomarkers (e.g., 14-3-3 protein), and definitive diagnosis by brain biopsy or post-mortem examination.
Treatment:
No curative treatment; management is supportive, focusing on symptom relief and palliative care.
Medications:
Symptomatic medications such as clonazepam or valproate for myoclonus and antipsychotics for behavioral symptoms. No specific disease-modifying drugs are available .
Prevalence:
How common the health condition is within a specific population.
Extremely rare; sporadic Creutzfeldt-Jakob Disease (sCJD) occurs in approximately 1–2 cases per million people per year.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Family history of prion diseases, exposure to infected tissue (e.g., through surgical instruments or contaminated beef in bovine spongiform encephalopathy).
Prognosis:
The expected outcome or course of the condition over time.
Poor prognosis; typically fatal within months to a year of symptom onset.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Rapid neurodegeneration, complete loss of cognitive and motor functions, and death.
Ramsay Hunt Syndrome
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
painful vesicular rash around the ear; facial paralysis on the affected side; hearing loss; tinnitus; vertigo; loss of taste on the anterior two-thirds of the tongue
Root Cause:
Reactivation of the varicella-zoster virus (VZV) in the geniculate ganglion of the facial nerve.
How it's Diagnosed: videos
Clinical presentation (facial paralysis and vesicular rash), PCR testing of vesicular fluid for VZV, MRI to exclude other causes of facial nerve palsy if needed.
Treatment:
Antiviral therapy (e.g., acyclovir or valacyclovir), corticosteroids (e.g., prednisone) to reduce inflammation, analgesics for pain management.
Medications:
Antivirals (e.g., acyclovir , valacyclovir ), corticosteroids (e.g., prednisone ), and pain management medications (e.g., gabapentin , opioids if severe).
Prevalence:
How common the health condition is within a specific population.
Rare; accounts for 12% of all facial paralysis cases.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Advanced age, immunosuppression, history of varicella infection.
Prognosis:
The expected outcome or course of the condition over time.
Recovery of facial nerve function occurs in 70–90% of cases with early treatment; delayed treatment or severe initial symptoms reduce the likelihood of full recovery.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Permanent facial weakness, hearing loss, post-herpetic neuralgia, and eye damage due to incomplete eyelid closure.
Skull Base, Petrous Apex, Infection
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
persistent headache; cranial nerve palsies (iii, iv, vi); ear pain; otorrhea; facial pain; fever
Root Cause:
Infection involving the petrous apex of the temporal bone, often resulting from chronic otitis media, mastoiditis, or direct extension of skull base infections.
How it's Diagnosed: videos
Imaging with CT or MRI to evaluate the extent of infection, blood cultures to identify causative organisms, and sometimes biopsy of infected tissue.
Treatment:
Prolonged course of intravenous antibiotics tailored to the pathogen, possible surgical drainage or debridement if abscess or extensive bony involvement occurs.
Medications:
Broad-spectrum antibiotics such as ceftriaxone or piperacillin-tazobactam initially, adjusted based on culture results. Antifungal agents (e.g., voriconazole ) if fungal infection is suspected.
Prevalence:
How common the health condition is within a specific population.
Rare due to the availability of antibiotics for otitis media; typically seen in immunocompromised individuals or those with delayed treatment.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Chronic ear infections, skull trauma, immunosuppression, and inadequate treatment of preceding infections.
Prognosis:
The expected outcome or course of the condition over time.
With timely treatment, good prognosis; delayed or untreated cases can lead to serious complications.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Cranial nerve damage, brain abscess, meningitis, and cavernous sinus thrombosis.
Spinal Epidural Abscess
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; localized back pain; neurological deficits (e.g., weakness, numbness, or paralysis); difficulty walking; bowel or bladder dysfunction
Root Cause:
Accumulation of pus in the epidural space of the spine, typically caused by bacterial infection (commonly Staphylococcus aureus).
How it's Diagnosed: videos
Magnetic Resonance Imaging (MRI) with contrast; blood cultures; complete blood count (CBC); inflammatory markers like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).
Treatment:
Prompt surgical drainage and antibiotic therapy.
Medications:
Broad-spectrum antibiotics such as vancomycin (glycopeptide class) combined with ceftriaxone (cephalosporin class) or piperacillin-tazobactam (penicillin/beta-lactamase inhibitor class). Adjusted based on culture and sensitivity results.
Prevalence:
How common the health condition is within a specific population.
Rare; incidence estimated at 2-3 cases per 10,000 hospital admissions annually.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Diabetes, intravenous drug use, spinal trauma or surgery, immunosuppression, bacteremia or sepsis.
Prognosis:
The expected outcome or course of the condition over time.
Good with early diagnosis and treatment; delayed intervention can lead to permanent neurological deficits or death.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Paralysis, chronic pain, sepsis, spinal instability, recurrent infections.
Spinal Infections
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
back pain; fever; neurological deficits; localized tenderness; malaise
Root Cause:
Infections of spinal tissues caused by bacteria, fungi, or, rarely, viruses.
How it's Diagnosed: videos
MRI with contrast, blood cultures, biopsy of infected tissue, inflammatory markers (CRP, ESR).
Treatment:
Antibiotics or antifungal agents; sometimes surgical intervention for abscess drainage or decompression.
Medications:
Antibiotics such as vancomycin (glycopeptide) for gram-positive organisms; ceftriaxone (cephalosporin) or piperacillin-tazobactam for gram-negative bacteria. For fungal infections, amphotericin B or fluconazole (antifungal agents).
Prevalence:
How common the health condition is within a specific population.
Rare; incidence depends on the specific condition within spinal infections.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Immunosuppression, diabetes, intravenous drug use, recent surgery, systemic infections.
Prognosis:
The expected outcome or course of the condition over time.
Good with timely treatment; delays can lead to permanent neurological damage.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Neurological deficits, chronic infection, sepsis, spinal deformities.
St. Louis Encephalitis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; headache; stiff neck; disorientation; tremors; seizures; coma in severe cases
Root Cause:
Viral infection caused by the St. Louis encephalitis virus (SLEV), transmitted by mosquitoes.
How it's Diagnosed: videos
Detection of SLEV-specific IgM antibodies in serum or cerebrospinal fluid (CSF) via ELISA; polymerase chain reaction (PCR).
Treatment:
Supportive care; no specific antiviral treatment.
Medications:
Symptomatic treatments, including antipyretics (e.g., acetaminophen ), anticonvulsants for seizures, and corticosteroids for severe inflammation (if indicated).
Prevalence:
How common the health condition is within a specific population.
Sporadic outbreaks in North America, particularly in the summer and early fall.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Mosquito exposure, older age, immunosuppression, residing in endemic areas.
Prognosis:
The expected outcome or course of the condition over time.
Varies; mild cases recover fully, while severe cases may have residual neurological deficits or mortality.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Persistent neurological issues, cognitive deficits, mortality in severe cases.
Staphylococcal Meningitis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; severe headache; neck stiffness; nausea; vomiting; altered mental status; seizures
Root Cause:
Infection of the meninges caused by Staphylococcus aureus or other staphylococcal species, often following surgery, trauma, or bacteremia.
How it's Diagnosed: videos
Lumbar puncture with CSF analysis; Gram staining and culture; blood cultures.
Treatment:
Intravenous antibiotics tailored to culture sensitivity.
Medications:
Empiric therapy often includes vancomycin (glycopeptide) combined with ceftriaxone or meropenem (carbapenem). Adjusted based on susceptibility.
Prevalence:
How common the health condition is within a specific population.
Rare; higher in healthcare-associated settings.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Neurosurgery, trauma, immunosuppression, systemic staphylococcal infections.
Prognosis:
The expected outcome or course of the condition over time.
Good with early treatment; poor in untreated or advanced cases.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Brain abscesses, hearing loss, neurological deficits, septic shock.
Subdural Empyema
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; severe headache; nausea; altered mental status; focal neurological deficits; seizures
Root Cause:
Collection of pus between the dura mater and arachnoid membrane, often caused by bacterial infection spreading from sinuses or middle ear.
How it's Diagnosed: videos
MRI with contrast; CT scan; blood cultures.
Treatment:
Surgical drainage combined with antibiotic therapy.
Medications:
Broad-spectrum antibiotics, such as vancomycin (glycopeptide) with ceftriaxone (cephalosporin) or metronidazole (nitroimidazole class) for anaerobic coverage.
Prevalence:
How common the health condition is within a specific population.
Rare; more common in males and children with sinus infections.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Sinusitis, otitis media, skull trauma, neurosurgery.
Prognosis:
The expected outcome or course of the condition over time.
Good with timely intervention; delayed treatment increases risk of mortality and morbidity.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Brain abscess, cerebral venous thrombosis, neurological deficits, sepsis.
Tetanus
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
muscle stiffness; lockjaw (trismus); painful muscle spasms; difficulty swallowing; fever; sweating
Root Cause:
Caused by Clostridium tetani bacteria, which release tetanospasmin, a toxin that interferes with motor neuron signaling, leading to muscle rigidity and spasms.
How it's Diagnosed: videos
Based on clinical symptoms and history of injury; no definitive lab test but may include wound culture for C. tetani.
Treatment:
Wound care, administration of tetanus immunoglobulin (TIG), supportive care (e.g., muscle relaxants, ventilatory support if needed), and antibiotics.
Medications:
Penicillin G or metronidazole (antibiotics to eradicate C. tetani), diazepam or baclofen (muscle relaxants to control spasms).
Prevalence:
How common the health condition is within a specific population.
Rare in developed countries due to vaccination; most cases occur in unvaccinated individuals or in areas with poor healthcare access.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Unvaccinated status, puncture wounds, animal bites, burns, or other injuries contaminated with soil or feces.
Prognosis:
The expected outcome or course of the condition over time.
Can be life-threatening if untreated; with appropriate care, survival is high, but recovery may take weeks to months.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Respiratory failure, fractures from severe spasms, autonomic dysfunction, secondary infections, and death if untreated.
Tropical Myeloneuropathies
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
progressive weakness; spastic paralysis; gait abnormalities; sensory disturbances; urinary incontinence
Root Cause:
Often linked to dietary deficiencies (e.g., vitamin B12) or infections (e.g., HTLV-1 virus), leading to spinal cord or nerve damage.
How it's Diagnosed: videos
Clinical examination, blood tests (e.g., for vitamin deficiencies or HTLV-1 serology), MRI, and nerve conduction studies.
Treatment:
Address underlying causes, nutritional supplementation, antiviral therapy if HTLV-1 related, and physical rehabilitation.
Medications:
Antiretroviral agents for HTLV-1 (e.g., zidovudine ); vitamin B12 or folic acid supplements if deficiency is present.
Prevalence:
How common the health condition is within a specific population.
Rare, primarily found in tropical and subtropical regions.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Malnutrition, exposure to HTLV-1, genetic predisposition, and environmental factors.
Prognosis:
The expected outcome or course of the condition over time.
Variable; can be managed with early intervention but may lead to chronic disability in severe cases.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Chronic disability, loss of mobility, and secondary infections.
Tuberculous Meningitis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
headache; fever; nausea; vomiting; stiff neck; altered mental status; seizures
Root Cause:
Infection of the meninges by Mycobacterium tuberculosis, leading to inflammation and increased intracranial pressure.
How it's Diagnosed: videos
Lumbar puncture with CSF analysis (increased protein, low glucose, and lymphocytic predominance), imaging (MRI or CT), and microbiological tests for M. tuberculosis.
Treatment:
Long-term combination antitubercular therapy (e.g., isoniazid, rifampin, pyrazinamide, ethambutol), corticosteroids to reduce inflammation, and supportive care.
Medications:
First-line antitubercular drugs (e.g., isoniazid , rifampin ); corticosteroids (e.g., dexamethasone ) to manage inflammation.
Prevalence:
How common the health condition is within a specific population.
More common in areas with high TB burden; rare in developed countries.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
HIV infection, immunosuppression, close contact with TB patients, malnutrition.
Prognosis:
The expected outcome or course of the condition over time.
With early treatment, survival is possible, but delayed therapy can result in high morbidity and mortality.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Hydrocephalus, stroke, cranial nerve palsies, cognitive deficits, and death if untreated.
Venezuelan Equine Encephalitis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; headache; nausea; vomiting; seizures; confusion; weakness; photophobia
Root Cause:
Caused by the Venezuelan equine encephalitis virus, transmitted by mosquitoes, leading to inflammation of the brain.
How it's Diagnosed: videos
Serologic tests for viral antibodies (e.g., ELISA), PCR for viral RNA, and CSF analysis.
Treatment:
Supportive care (e.g., hydration, antipyretics, and seizure control); no specific antiviral treatment available.
Medications:
Antipyretics (e.g., acetaminophen for fever); anticonvulsants (e.g., phenytoin or valproic acid for seizures).
Prevalence:
How common the health condition is within a specific population.
Sporadic outbreaks in Central and South America; rare in humans, more common in equines.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Living or working in endemic areas, exposure to mosquitoes, and outdoor activities.
Prognosis:
The expected outcome or course of the condition over time.
Most recover fully, but severe cases may lead to neurological deficits or death.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Long-term neurological sequelae (e.g., cognitive deficits, epilepsy), and in severe cases, death.
Viral Encephalitis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; headache; confusion; seizures; nausea; vomiting; altered mental status; photophobia
Root Cause:
Brain inflammation caused by viral infections (e.g., herpes simplex virus, arboviruses), leading to neuronal damage.
How it's Diagnosed: videos
Clinical evaluation, CSF analysis, PCR for viral DNA/RNA, and neuroimaging (e.g., MRI).
Treatment:
Antiviral therapy for specific viruses (e.g., acyclovir for herpes simplex virus); supportive care for other viral causes.
Medications:
Acyclovir (for herpes simplex); antipyretics (e.g., ibuprofen for fever); anticonvulsants (e.g., levetiracetam for seizures).
Prevalence:
How common the health condition is within a specific population.
Varies; common in areas with high mosquito-borne virus activity or sporadic herpes outbreaks.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Immunosuppression, unvaccinated status, and mosquito exposure.
Prognosis:
The expected outcome or course of the condition over time.
Depends on the cause and severity; early treatment improves outcomes, but severe cases may result in lasting deficits.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Long-term neurological damage, seizures, cognitive deficits, and death if untreated.
Viral Meningitis
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
headache; fever; neck stiffness; photophobia; nausea; vomiting
Root Cause:
Inflammation of the meninges caused by viral infections (e.g., enteroviruses, herpesviruses), leading to non-purulent inflammation.
How it's Diagnosed: videos
CSF analysis (increased lymphocytes, normal glucose, elevated protein), PCR for viral pathogens.
Treatment:
Supportive care (hydration, pain relief, antipyretics); antiviral therapy for specific causes (e.g., herpesvirus).
Medications:
Acyclovir (for herpes-related cases); over-the-counter analgesics (e.g., acetaminophen for headache and fever).
Prevalence:
How common the health condition is within a specific population.
Common; most cases are mild and self-limiting.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Exposure to infected individuals, immunosuppression, and travel to endemic regions.
Prognosis:
The expected outcome or course of the condition over time.
Excellent in most cases; severe outcomes are rare.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Rare; may include chronic headaches or recurrent symptoms.
West Nile Virus (WNV) Infection and Encephalitis (WNE)
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; headache; muscle weakness; fatigue; seizures; confusion; stiff neck
Root Cause:
Viral infection transmitted by mosquitoes, leading to inflammation of the brain and nervous system.
How it's Diagnosed: videos
PCR or serology for WNV in blood or CSF; neuroimaging may reveal inflammation.
Treatment:
Supportive care (hydration, pain management, seizure control); no specific antiviral therapy.
Medications:
Analgesics for pain relief (e.g., acetaminophen ); anticonvulsants (e.g., levetiracetam for seizures).
Prevalence:
How common the health condition is within a specific population.
Found in many parts of the world, especially during mosquito season.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Outdoor activities, lack of mosquito control, immunosuppression.
Prognosis:
The expected outcome or course of the condition over time.
Most recover, but severe cases may result in neurological deficits or death.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Chronic fatigue, cognitive impairment, and long-term neurological deficits in severe cases.
Western Equine Encephalitis (WEE)
Specialty: Infectious Diseases
Category: CNS Infections
Symptoms:
fever; headache; nausea; vomiting; seizures; altered mental status; muscle weakness
Root Cause:
Caused by the Western equine encephalitis virus, transmitted by mosquitoes, leading to inflammation of the brain and central nervous system.
How it's Diagnosed: videos
Serologic testing for viral antibodies (e.g., IgM ELISA), PCR for viral RNA, and CSF analysis.
Treatment:
Supportive care (e.g., intravenous fluids, fever control, seizure management); no specific antiviral therapy available.
Medications:
Antipyretics (e.g., ibuprofen for fever and discomfort); anticonvulsants (e.g., diazepam or levetiracetam for seizure control).
Prevalence:
How common the health condition is within a specific population.
Rare; found in North and South America, with sporadic outbreaks in rural areas.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Exposure to mosquitoes in endemic regions, outdoor activities, and lack of mosquito control.
Prognosis:
The expected outcome or course of the condition over time.
Most cases are mild and resolve without long-term effects; severe cases can lead to neurological deficits or death, particularly in children and the elderly.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Long-term neurological deficits (e.g., cognitive impairment, motor dysfunction), seizures, and death in severe cases.